You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

355 Results
Document
New
Jun 2025
Document
New
Jun 2025
Document
New
Jun 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Document
New
Jul 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
amivantamab (Unfunded),
lazertinib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jul 2025
Guidelines and Advice
Status: Current
Updated
Aug 2025
Drug
Other Name(s): Vitrakvi®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2025
Guidelines and Advice
Status: Current
ID: GL 16-3
Version: 3
Mar 2022
Drug
Other Name(s): Reblozyl®
Quick Link(s): Drug Monograph, Patient Info Sheet
Sep 2025

Pages